A new pyrroline compound selective for I1-imidazoline receptors improves metabolic syndrome in rats.
about
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation.Central Sympathetic Modulation Reverses Microvascular Alterations in a Rat Model of High-Fat Diet-Induced Metabolic Syndrome.Imidazoline-like drugs improve insulin sensitivity through peripheral stimulation of adiponectin and AMPK pathways in a rat model of glucose intolerance.
P2860
A new pyrroline compound selective for I1-imidazoline receptors improves metabolic syndrome in rats.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A new pyrroline compound selec ...... es metabolic syndrome in rats.
@en
A new pyrroline compound selec ...... es metabolic syndrome in rats.
@nl
type
label
A new pyrroline compound selec ...... es metabolic syndrome in rats.
@en
A new pyrroline compound selec ...... es metabolic syndrome in rats.
@nl
prefLabel
A new pyrroline compound selec ...... es metabolic syndrome in rats.
@en
A new pyrroline compound selec ...... es metabolic syndrome in rats.
@nl
P2093
P356
P1476
A new pyrroline compound selec ...... ves metabolic syndrome in rats
@en
P2093
Adeline Muscat
Claude Julien
Gérard Chetrite
Hugues Greney
Jean-Pierre Max
Lyne Fellmann
Nathalie Niederhoffer
Pascal Bousquet
Patrick Lacolley
P304
P356
10.1124/JPET.113.205328
P407
P577
2013-07-01T00:00:00Z